a, a N Clinical Trials

A listing of a, a N clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1940 clinical trials
A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma

This is a first-in-human Phase I, open-label, multicenter, global, dose-escalation study designed to evaluate the safety, tolerability, and pharmacokinetics of RO7297089 and make a preliminary assessment of anti-tumor activity in patients with R/R MM for whom no established therapy for MM is appropriate and available or who are intolerant to …

refractory multiple myeloma
measurable disease
multiple myeloma
  • 0 views
  • 19 Feb, 2024
  • 5 locations
A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET

A Phase II trial aiming to assess the safety and activity of the combination of cabozantinib plus lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumor (NET): The LOLA trial

prrt
activated partial thromboplastin time
thrombin
24-hour urine protein test
hair thinning
  • 0 views
  • 19 Feb, 2024
  • 1 location
Test Campaign Performance Report  

Test Campaign Performance Report

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MPP2+ Recurrent or Progressive Glioblastoma

Vaccines made from a gene-modified virus may help the body build an effective immune response to kill tumor cells.

malignant glioma
immunohistochemistry
leukapheresis
HIV Infection
expression by immunohistochemistry
  • 0 views
  • 19 Feb, 2024
  • 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

Tipifarnib may block the growth of cancer cells that have specific genetic changes in a gene called HRAS and may reduce tumor size.

antineoplastic agents
anti-cancer agents
metastases
measurable disease
recurrent ewing sarcoma
  • 0 views
  • 19 Feb, 2024
  • 83 locations
A Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of UCB8600 in Healthy Participants Atopic Participants and Chronic Spontaneous Urticaria Participants

The purpose of the study is to assess safety, tolerability and pharmacokinetics (PK) of oral UCB8600.

antihistamines
immunoglobulin
12-lead electrocardiogram
tree pollen
acute illness
  • 0 views
  • 19 Feb, 2024
  • 1 location
Impact of a Double-reading Animated Film (Child Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating Room

Preoperative anxiety affects 40 to 60% of children. A literature review concluded that effective preparation strategies must involve parents, must be appropriate to their age and proposed upstream of the intervention.

anxiety
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CC-98633 BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed and/or Refractory Multiple Myeloma

The study will consist of 2 parts: dose-escalation (Part A) and dose-expansion (Part B). The dose-escalation part (Part A) of the study is to evaluate the safety and tolerability of increasing dose levels of CC-98633 to establish a recommended Phase 2 dose (RP2D); and the dose-expansion part (Part B) of …

bortezomib
immunotherapeutic agent
bcma
proteasome inhibitor
daratumumab
  • 0 views
  • 19 Feb, 2024
  • 9 locations
Prevention of Preterm Birth by Screening of the Consistency Index and Length of the Uterine Cervix in Women With a Single Pregnancy

Worldwide, about 15 million babies are born too soon every year, causing 1.1 million deaths, as well as shortand long-term disability in countless survivors. Few prognostic tests are available to predict PTB. A short transvaginal ultrasound cervical length (TVU CL) has been shown to be a good predictor of PTB. …

uterine cervix
pregnancy preterm
perinatal morbidity
transvaginal ultrasound
premature birth
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of MRG002 in Patients With HER2-Positive Advanced Solid Tumors and Locally Advanced or Metastatic Gastric/Gastroesophageal Junction (GEJ) Cancer

The objective of this study is to assess the safety, efficacy, and pharmacokinetics of MRG002, as well as the immunogenicity as defined by the incidence of anti-drug antibody (ADA) of MRG002 in patients with HER2-positive advanced solid tumors and locally advanced or metastatic gastric/gastroesophageal junction (GEJ) cancer.

  • 0 views
  • 19 Feb, 2024
  • 1 location